Evaluation of morbidity in Schistosoma mansoni -positive primary and secondary school children after four years of mass drug administration of praziquantel in western Kenya

ConclusionsWe did not detect differences in morbidity markers measured in a population of those infected or re-infected after multiple MDA. This could have been due to their relative insensitivity or a failure of MDA to prevent morbidity among those who remain infected. High malaria transmission in this area and/or a lack of suitable methods to measure the more subtle functional morbidities caused by schistosomiasis could be a factor. Further research is needed to identify and develop well-defined, easily quantifiableS. mansoni morbidity markers for this age group.
Source: Infectious Diseases of Poverty - Category: Infectious Diseases Source Type: research